Big data analytics enable companies to predict not just what can go wrong but also what needs to go right . Logistics service providers can track and generate data on any parameter in the pharma and medical device cold chain – temperature , humidity , CO2 levels , energy consumption , and even an event such as a door opening or closing . And of course the fact that this data can be transmitted via mobile devices means that key processes can be monitored in real time from anywhere in the world .
Now , using rich analytics algorithms , life sciences and healthcare companies can turn raw data such as this into predictive data , creating not just actionable warnings but also actionable insights and recommendations . These improve storage and handover processes , and prevent cold chain failure before it occurs . They also provide valuable competitive advantage .
What this means in a very practical sense is that new technologies are not only enabling auditable compliance with regulatory requirements but also helping life sciences and healthcare organisations to ensure alignment of logistics and transportation processes with business objectives .
Effective analytics enables each company to identify new ways to grow the enterprise with better methods of storing and transporting pharmaceuticals and medical devices , predicting demand and improving inventory management , and getting closer to customers and patients . Digital transformation is progressing rapidly in logistics , transportation and the supply chain , and DHL has the knowledge , experience and infrastructure to support life sciences and healthcare customers through these changes .
Since 2010 , we have completed over one million DHL SmartSensor shipments and contributed over 160 million temperature measurements in the supply chain . We have 4,900 life sciences and healthcare-dedicated staff , 150 + pharmacists , and 90 + life sciences-certified stations . In addition , we have 150 + life sciencesgraded warehouses , 15 + GMP ( good manufacturing practice ) -certified sites , and 20 + clinical trial depots . And we continue to make substantial investment in the development and deployment of technology innovations so that we successfully deliver healthcare to the world .
23